MCNS
MCID: LPD004
MIFTS: 48

Lipoid Nephrosis (MCNS) malady

Categories: Rare diseases, Nephrological diseases

Aliases & Classifications for Lipoid Nephrosis

Aliases & Descriptions for Lipoid Nephrosis:

Name: Lipoid Nephrosis 12 14 69
Minimal Change Disease 12 50
Nephrotic Syndrome with Lesion of Minimal Change Glomerulonephritis 12
Nephrotic Syndrome with Lesion of Minimal Change Nephrotic Syndrome 12
Idiopathic Minimal Change Nephrotic Syndrome 50
Glomerulonephritis, Minimal Change 69
Nephrotic Syndrome, Minimal Change 69
Minimal Change Glomerulonephritis 12
Minimal Change Nephrotic Syndrome 50
Nephrotic Syndrome Minimal Change 52
Minimal Change Glomerulopathy 50
Nephrosis, Lipoid 42
Mcns 50

Classifications:



External Ids:

Disease Ontology 12 DOID:10966
ICD10 33 N04
MeSH 42 D009402
NCIt 47 C34844
SNOMED-CT 64 197592009 44785005
UMLS 69 C0027721

Summaries for Lipoid Nephrosis

NIH Rare Diseases : 50 minimal change disease is a kidney disorder that can lead to nephrotic syndrome, although the nephrons of the kidney look normal under a regular microscope. the most common symptom is swelling around the eyes, face, abdomen, and legs. other features include poor appetite, weight gain, and a foamy appearance of the urine. the cause of minimal change disease is unknown, but it may occur following an allergic reaction, immunization, or viral infection. treatment may involve the use of steroids such as prednisone. children often respond better to this therapy than adults. those who experience repeated relapses may benefit from the use of cytotoxic therapy, including cyclophosphamide, cyclosporine or chlorambucil. last updated: 8/4/2011

MalaCards based summary : Lipoid Nephrosis, also known as minimal change disease, is related to focal segmental glomerulosclerosis and idiopathic steroid-sensitive nephrotic syndrome with minimal change. An important gene associated with Lipoid Nephrosis is IL13 (Interleukin 13), and among its related pathways/superpathways are NF-kappaB Signaling and Jak-STAT signaling pathway (KEGG). The drugs Citalopram and Ezetimibe have been mentioned in the context of this disorder. Affiliated tissues include kidney, eye and t cells, and related phenotype is renal/urinary system.

Wikipedia : 71 Minimal change disease (also known as MCD and nil disease, among others) is a disease affecting the... more...

Related Diseases for Lipoid Nephrosis

Diseases related to Lipoid Nephrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 109)
id Related Disease Score Top Affiliating Genes
1 focal segmental glomerulosclerosis 31.9 CD2AP NPHS1 NPHS2
2 idiopathic steroid-sensitive nephrotic syndrome with minimal change 10.8
3 c1q nephropathy 10.7
4 papillary adenocarcinoma 10.3 IL10 IL13
5 pauci-immune glomerulonephritis 10.3 NPHS1 NPHS2
6 diabetic angiopathy 10.3 CD79A IL10
7 inflammatory breast carcinoma 10.3 CD79A IL10
8 atopic dermatitis 6 10.3 ALB CD79A
9 tarsal tunnel syndrome 10.3 IL10 IL13
10 glaucoma 1, open angle, e 10.3 NPHS1 NPHS2
11 renal agenesis, unilateral 10.2 CD2AP NPHS2
12 colloid adenoma 10.2 ALB CD79A
13 schneiderian carcinoma 10.2 ALB CD79A
14 brown shrimp allergy 10.2 CD79A IL10
15 glomerulonephritis 10.2
16 striatonigral degeneration 10.2 ALB CD79A
17 infertility due to extratesticular cause 10.2 ALB CD79A
18 spastic diplegia 10.2 CD79A IL13
19 congenital nystagmus 10.2 ALB CD79A
20 male genital organ stricture 10.2 ALB CD79A
21 loiasis 10.2 CD79A IL10 IL13
22 eyelid neoplasm 10.2 CD79A IL10 IL13
23 acquired polycythemia 10.2 CD79A IL10 IL13
24 exudative vitreoretinopathy 2, x-linked 10.2 ALB IL13
25 actinic keratosis 10.2 CD79A IL10 IL13
26 indian plum allergy 10.2 IL10 IL13
27 xanthogranulomatous cholecystitis 10.2 CD79A IL10 IL13
28 childhood choriocarcinoma of the testis 10.2 CD79A IL10 IL13
29 paratyphoid fever 10.2 ALB IL10 IL13
30 crustacean allergy 10.2 IL13 IL4R
31 ciliary discoordination, due to random ciliary orientation 10.2 ALB CD79A IL10
32 aphthous stomatitis 10.2 ALB NPHS1 NPHS2
33 tarp syndrome 10.2 ALB CD79A
34 sick sinus syndrome 3 10.2 CD2AP NPHS1 NPHS2
35 anterior foramen magnum meningioma 10.2 ALB CD79A IL10
36 coronary artery dissection, spontaneous 10.2 ALB CD79A
37 congenital torticollis 10.1 CD2AP NPHS1 NPHS2
38 plantar wart 10.1 CD79A IL10
39 frasier syndrome 10.1 CD2AP NPHS1 NPHS2
40 nephropathy with pretibial epidermolysis bullosa and deafness 10.1 ALB CD79A IL10
41 foodborne botulism 10.1 ALB CD79A IL10
42 deafness, autosomal recessive 51 10.1 CD2AP NPHS1 NPHS2
43 acral persistent papular mucinosis 10.1 CD2AP NPHS1 NPHS2
44 uterine ligament clear cell adenocarcinoma 10.1 ALB CD79A IL10
45 acute cervicitis 10.1 ALB CD79A
46 goat milk allergy 10.1 IL10 IL13 IL4R
47 bare lymphocyte syndrome, type i 10.1 CCL2 IL10 IL13
48 fallopian tube endometriosis 10.1 ALB CD79A IL13
49 membranoproliferative glomerulonephritis 10.1 ALB CD79A IL10
50 childhood malignant hemangiopericytoma 10.1 ALB CD79A IL10

Graphical network of the top 20 diseases related to Lipoid Nephrosis:



Diseases related to Lipoid Nephrosis

Symptoms & Phenotypes for Lipoid Nephrosis

MGI Mouse Phenotypes related to Lipoid Nephrosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 renal/urinary system MP:0005367 9.17 ALB CD2AP CD79A NAGLU NPHS1 NPHS2

Drugs & Therapeutics for Lipoid Nephrosis

Drugs for Lipoid Nephrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1270)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Citalopram Approved Phase 4,Phase 3,Phase 1 59729-33-8 2771
2
Ezetimibe Approved Phase 4,Phase 2,Early Phase 1 163222-33-1 150311
3
Magnesium oxide Approved Phase 4,Phase 3 1309-48-4 14792
4
Lamotrigine Approved, Investigational Phase 4,Phase 3 84057-84-1 3878
5
Isoflurane Approved, Vet_approved Phase 4,Phase 3 26675-46-7 3763
6
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 2078-54-8 4943
7
Remifentanil Approved Phase 4,Phase 1,Phase 2 132875-61-7 60815
8
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-78-2 2244
9
Cilostazol Approved Phase 4 73963-72-1 2754
10
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
11
Methylphenidate Approved, Investigational Phase 4,Phase 3,Phase 2 113-45-1 4158
12
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 7439-89-6 23925
13
Selenium Approved, Vet_approved Phase 4,Phase 2,Phase 3,Early Phase 1 7782-49-2
14
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2 159351-69-6 6442177
15
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
16
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
17
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
18
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
19
Ranibizumab Approved Phase 4,Phase 3,Phase 1,Phase 2 347396-82-1 459903
20
Didanosine Approved Phase 4 69655-05-6 50599
21
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
22
Lamivudine Approved, Investigational Phase 4,Phase 3,Phase 2 134678-17-4 60825
23
Benazepril Approved, Investigational Phase 4 86541-75-5 5362124
24
Candesartan Approved Phase 4,Phase 1 139481-59-7 2541
25
Enalapril Approved, Vet_approved Phase 4,Phase 2 75847-73-3 5362032 40466924
26
Enalaprilat Approved Phase 4,Phase 2 76420-72-9 6917719
27
Eprosartan Approved Phase 4 133040-01-4 5281037
28
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
29
Fosinopril Approved Phase 4 98048-97-6 55891
30
Irbesartan Approved, Investigational Phase 4 138402-11-6 3749
31
Lisinopril Approved, Investigational Phase 4 83915-83-7 5362119
32
Losartan Approved Phase 4 114798-26-4 3961
33
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
34
Olmesartan Approved, Investigational Phase 4 144689-24-7, 144689-63-4 158781 130881
35
Perindopril Approved Phase 4 107133-36-8, 82834-16-0 107807
36
Quinapril Approved, Investigational Phase 4,Phase 3 85441-61-8 54892
37
Ramipril Approved Phase 4,Phase 2,Phase 3 87333-19-5 5362129
38
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
39
Sevoflurane Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 28523-86-6 5206
40
Telmisartan Approved, Investigational Phase 4,Phase 2 144701-48-4 65999
41
Trandolapril Approved Phase 4 87679-37-6 5484727
42
Valsartan Approved, Investigational Phase 4,Phase 3 137862-53-4 60846
43
Polidocanol Approved Phase 4 9002-92-0
44
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
45
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
46
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 128794-94-5 5281078
47
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 24280-93-1 446541
48
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
49
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1 2216-51-5 16666
50
Nebivolol Approved, Investigational Phase 4 152520-56-4, 99200-09-6, 118457-14-0 71301

Interventional clinical trials:

(show top 50) (show all 2834)
id Name Status NCT ID Phase
1 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
2 Treatment Youth With Obsessive-Compulsive Disorder Unknown status NCT00708240 Phase 4
3 The Effects of Ezetimibe on Coronary Plaque Volume in Patients With Acute Coronary Syndrome Unknown status NCT01068093 Phase 4
4 Magnesium in Liver Cirrhosis Unknown status NCT01894867 Phase 4
5 Iloperidone in Mixed States of Bipolar Disorder Unknown status NCT02413918 Phase 4
6 Graft Patency After FFR-guided Versus Angio-guided CABG (GRAFFITI) Trial Unknown status NCT01810224 Phase 4
7 Influence of Anesthesia on Mechanical Efficiency of Left Ventricle in Patients Undergoing Open Heart Surgery Unknown status NCT01397331 Phase 4
8 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
9 Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder Unknown status NCT01130467 Phase 4
10 Intravenous Iron in Patients With Anemia of Chronic Kidney Disease Unknown status NCT00204256 Phase 4
11 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4
12 Algorithm Guided Treatment Strategies for Bipolar Depression Unknown status NCT01938859 Phase 4
13 ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion Unknown status NCT00407940 Phase 4
14 Hemostasis in Kocher-Langenbeck Approaches for Acetabular Surgery Using a Topical Surgical Hemostat (Vitagel) Unknown status NCT01230931 Phase 4
15 Selenium Supplementation in Pregnancy Unknown status NCT01465867 Phase 4
16 Effects of DES Platforms on Markers of Endothelial Damage and Inflammation Unknown status NCT01489202 Phase 4
17 Closed-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy Unknown status NCT02114437 Phase 4
18 Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension Unknown status NCT01472796 Phase 4
19 Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia Unknown status NCT01904864 Phase 4
20 How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine? Unknown status NCT00749047 Phase 4
21 Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema Unknown status NCT02055911 Phase 4
22 Once Daily 3TC, Efavirenz and ddI for HIV Infection Unknown status NCT00214435 Phase 4
23 Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics Unknown status NCT01715584 Phase 4
24 Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy Unknown status NCT02166060 Phase 4
25 Sevoflurane Decreases the Risk of Postoperative Delirium After Cerebral Hypoxemia During Surgery Unknown status NCT02133638 Phase 4
26 An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst Unknown status NCT02154789 Phase 4
27 An Investigator-blind Multi-center Prospective Study for the Efficacy and Safety of Silicon Gel (Dermatix) Unknown status NCT01004536 Phase 4
28 Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations. Unknown status NCT00248716 Phase 4
29 Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia Unknown status NCT02243735 Phase 4
30 Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome Unknown status NCT01346007 Phase 4
31 Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR) Completed NCT01129284 Phase 4
32 Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) Completed NCT00246909 Phase 4
33 Dialogue Aimed at Reducing Anxiety in Patients With Severe COPD Completed NCT02366390 Phase 4
34 A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium Completed NCT01691482 Phase 4
35 Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD) Completed NCT01380717 Phase 4
36 Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease Completed NCT01124422 Phase 4
37 Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder Completed NCT00956514 Phase 4
38 Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) Completed NCT01770145 Phase 4
39 The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders Completed NCT00904709 Phase 4
40 Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder Completed NCT01080807 Phase 4
41 Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance Completed NCT01582165 Phase 4
42 Duloxetine Treatment in Elderly With Dysthymia Completed NCT01852383 Phase 4
43 Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States Completed NCT00143026 Phase 4
44 Memantine and Cognitive Dysfunction in Bipolar Disorder Completed NCT00586066 Phase 4
45 Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population Completed NCT01798225 Phase 4
46 Cognitive Enhancement in Bipolar Disorder Completed NCT00597896 Phase 4
47 Giardia Induced Fatigue and Functional Gastrointestinal Diseases Completed NCT00860236 Phase 4
48 Parathyroidectomy vs Cinacalcet in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation Completed NCT01178450 Phase 4
49 Validation of Subjective Rating Scales Used to Assess Surgical Conditions in Abdominal Surgery Completed NCT02079337 Phase 4
50 Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder Completed NCT00877487 Phase 4

Search NIH Clinical Center for Lipoid Nephrosis

Cochrane evidence based reviews: nephrosis, lipoid

Genetic Tests for Lipoid Nephrosis

Anatomical Context for Lipoid Nephrosis

MalaCards organs/tissues related to Lipoid Nephrosis:

39
Kidney, Eye, T Cells, Monocytes, Bone

Publications for Lipoid Nephrosis

Articles related to Lipoid Nephrosis:

(show top 50) (show all 115)
id Title Authors Year
1
50 Years Ago in TheJournal ofPediatrics: Effect of Cyclophosphamide on Lipoid Nephrosis in the Human and on Aminonucleoside Nephrosis in the Rat. ( 27017462 )
2016
2
Cytokine mRNA profile in lipoid nephrosis: evidence for increased IL-8 mRNA stability. ( 12138264 )
2002
3
T-cell lineage acute lymphoblastic leukemia with chromosome 5 abnormality in a patient with Crohn's disease and lipoid nephrosis. ( 10834511 )
2000
4
Interleukin 12 upregulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis. ( 9578066 )
1998
5
Changing perspective of lipoid nephrosis in Iranian children. ( 9874333 )
1998
6
Anti-interleukin 8 antibody abolishes effects of lipoid nephrosis cytokine. ( 9686956 )
1998
7
Interleukin 10 and interleukin 13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis. ( 9346389 )
1997
8
Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis. ( 9041534 )
1997
9
Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria. ( 8580016 )
1995
10
Decreased release of IL-10 by monocytes from patients with lipoid nephrosis. ( 8536379 )
1995
11
Inner ear damage due to lipoid nephrosis. ( 8357609 )
1993
12
Acquired factor VIII autoantibody (AAb) in the course of lipoid nephrosis. ( 8302482 )
1993
13
Proteinuria selectivity index--prognostic value in lipoid nephrosis and related diseases. ( 8247178 )
1993
14
Recombinant granulocyte-macrophage colony-stimulating factor modulates in vitro function of the peripheral blood mononuclear cells in lipoid nephrosis. ( 8342574 )
1993
15
Effect of methylprednisolone pulse therapy on cellular immunity abnormalities in a patient with lipoid nephrosis. ( 2077423 )
1990
16
[Renin activity and aldosterone level in the plasma of children with lipoid nephrosis]. ( 2251209 )
1990
17
Ibuprofen-associated lipoid nephrosis without interstitial nephritis. ( 2741936 )
1989
18
Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis. ( 2787718 )
1989
19
Interferon and lipoid nephrosis. ( 2458041 )
1988
20
A transient monocyte defective function in idiopathic nephrotic syndrome (lipoid nephrosis). ( 3170113 )
1988
21
An overlapping syndrome of IgA nephropathy and lipoid nephrosis. ( 3538845 )
1986
22
Evaluation of T colony-stimulating factor in patients with lipoid nephrosis. ( 3484545 )
1986
23
Impaired cellular immune responses in adult lipoid nephrosis patients. ( 4017301 )
1985
24
Depression of local graft-versus-host reaction in patients with lipoid nephrosis. ( 3876448 )
1985
25
Impaired T-lymphocyte colony formation in lipoid nephrosis. ( 3878248 )
1985
26
Is house dust allergen a possible causal factor for relapses in lipoid nephrosis? ( 6711772 )
1984
27
Defective cell-mediated immunity in lipoid nephrosis. ( 6230321 )
1984
28
Impaired delayed hypersensitivity in lipoid nephrosis. ( 6462316 )
1984
29
Alterations of T cell subpopulations in childhood lipoid nephrosis and its relation to immunosuppressive treatment. ( 6335580 )
1984
30
HLA-DR 7 in adult lipoid nephrosis patients. Significant difference according to the age of onset. ( 6603586 )
1983
31
Allergy and lipoid nephrosis. ( 6404133 )
1983
32
Adult onset lipoid nephrosis is not DR7 associated. ( 6415866 )
1983
33
In vitro lymphocyte dysfunction in lipoid nephrosis mediated by suppressor cells. ( 6218418 )
1982
34
Effect of thymic humoral factor on a local graft-versus-host reaction of lymphocytes in patients with lipoid nephrosis. ( 6984140 )
1982
35
Is lipoid nephrosis an "allergic" disease? ( 6217600 )
1982
36
Impaired local graft-versus-host reaction in lipoid nephrosis. ( 6981777 )
1982
37
The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft fA1r PAodiatrische Nephrologie (APN). ( 6752557 )
1982
38
Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. A possible T-lymphocyte disorder. ( 6977270 )
1982
39
Deacetyl-thymosin alpha 1: synthesis and immunological effect on lipoid nephrosis lymphocytes. ( 7116512 )
1982
40
Renal vein thrombosis complicating lipoid nephrosis. ( 7113197 )
1982
41
Concanavalin A-induced suppressor cell activity in lipoid nephrosis. ( 6458879 )
1981
42
Impaired cell-mediated immunity in lipoid nephrosis. ( 6977099 )
1981
43
Lipoid nephrosis appearing as acute oliguric renal failure. ( 7362359 )
1980
44
Lipoid nephrosis in the elderly. ( 7394611 )
1980
45
Congenital lipoid nephrosis with left renal vein thrombosis and Chiari's syndrome. ( 468879 )
1979
46
Significance of complement (C3) in lipoid nephrosis and glomerulonephritis. ( 730303 )
1978
47
Lipoid nephrosis and focal glomerulosclerosis. ( 355987 )
1978
48
Hodgkin's disease and lipoid nephrosis. ( 67327 )
1977
49
Nephrotic syndrome with minimal glomerular lesions (lipoid nephrosis) in an adult diabetic patient. ( 576799 )
1977
50
Postural proteinuria and lipoid nephrosis of 58 years' duration. ( 1009389 )
1976

Variations for Lipoid Nephrosis

Expression for Lipoid Nephrosis

Search GEO for disease gene expression data for Lipoid Nephrosis.

Pathways for Lipoid Nephrosis

GO Terms for Lipoid Nephrosis

Cellular components related to Lipoid Nephrosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.43 ALB CCL2 IL10 IL13 IL4R SERPINB7
2 slit diaphragm GO:0036057 8.62 NPHS1 NPHS2

Biological processes related to Lipoid Nephrosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.67 CCL2 IL10 IL13 IL4R
2 response to lipopolysaccharide GO:0032496 9.61 CCL2 IL10 IL13
3 B cell proliferation GO:0042100 9.46 CD79A IL10
4 negative regulation of endothelial cell apoptotic process GO:2000352 9.4 IL10 IL13
5 positive regulation of collagen biosynthetic process GO:0032967 9.32 CCL2 SERPINB7
6 defense response to protozoan GO:0042832 9.26 IL10 IL4R
7 positive regulation of mast cell degranulation GO:0043306 9.16 IL13 IL4R
8 positive regulation of immunoglobulin production GO:0002639 8.96 IL13 IL4R
9 positive regulation of macrophage activation GO:0043032 8.8 IL10 IL13 IL4R

Sources for Lipoid Nephrosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....